Nurix Therapeutics Inc (NRIX)
12.36
-1.39
(-10.11%)
USD |
NASDAQ |
Apr 25, 16:00
12.35
-0.01
(-0.08%)
After-Hours: 20:00
Nurix Therapeutics Price: 12.36 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 13.29 | 13.34 | 12.27 | 12.36 | 952723.0 |
Apr 24, 2024 | 14.05 | 14.42 | 13.52 | 13.75 | 519873.0 |
Apr 23, 2024 | 13.59 | 14.44 | 13.59 | 14.13 | 895076.0 |
Apr 22, 2024 | 13.69 | 14.10 | 13.30 | 13.58 | 574496.0 |
Apr 19, 2024 | 14.33 | 14.84 | 12.94 | 13.59 | 1.017M |
Apr 18, 2024 | 14.11 | 14.60 | 13.64 | 14.44 | 1.489M |
Apr 17, 2024 | 15.10 | 15.22 | 13.90 | 14.08 | 1.361M |
Apr 16, 2024 | 15.40 | 15.40 | 14.39 | 14.65 | 1.933M |
Apr 15, 2024 | 16.71 | 16.71 | 15.44 | 15.46 | 2.524M |
Apr 12, 2024 | 16.45 | 16.81 | 15.40 | 16.74 | 3.881M |
Apr 11, 2024 | 17.09 | 18.12 | 16.36 | 17.21 | 1.062M |
Apr 10, 2024 | 16.67 | 17.00 | 15.46 | 15.69 | 3.501M |
Apr 09, 2024 | 13.95 | 17.51 | 13.81 | 17.48 | 1.910M |
Apr 08, 2024 | 14.12 | 14.12 | 13.46 | 13.80 | 634223.0 |
Apr 05, 2024 | 14.14 | 14.16 | 13.51 | 13.90 | 416768.0 |
Apr 04, 2024 | 14.75 | 15.19 | 13.80 | 13.94 | 921812.0 |
Apr 03, 2024 | 14.67 | 14.77 | 13.77 | 14.59 | 621361.0 |
Apr 02, 2024 | 14.21 | 15.12 | 13.92 | 14.86 | 763860.0 |
Apr 01, 2024 | 14.59 | 15.28 | 14.13 | 14.58 | 936713.0 |
Mar 28, 2024 | 14.54 | 15.36 | 14.17 | 14.70 | 1.312M |
Mar 27, 2024 | 13.19 | 14.61 | 12.55 | 14.54 | 1.391M |
Mar 26, 2024 | 13.81 | 14.36 | 12.91 | 13.02 | 672044.0 |
Mar 25, 2024 | 13.45 | 14.44 | 13.36 | 13.53 | 549000.0 |
Mar 22, 2024 | 13.09 | 13.48 | 12.77 | 13.42 | 531994.0 |
Mar 21, 2024 | 13.48 | 13.83 | 13.02 | 13.02 | 498694.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.25
Minimum
Oct 25 2023
50.17
Maximum
Jan 19 2021
19.26
Average
14.59
Median
Nov 11 2022
Price Benchmarks
Gilead Sciences Inc | 65.27 |
ALX Oncology Holdings Inc | 16.87 |
Vanda Pharmaceuticals Inc | 4.48 |
GlycoMimetics Inc | 1.71 |
Immunic Inc | 1.26 |
Price Related Metrics
PS Ratio | 8.336 |
Price to Book Value | 4.473 |
Earnings Yield | -21.52% |
Market Cap | 754.79M |